Clinical Trials Browser

OTHER × Pathologic Complete Response × 130-nm albumin-bound paclitaxel × Clear all

NCT07618793 2026-06-01

Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma

Phase 2 Not yet recruiting

Pathologic Complete Response, Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT07353723 2026-01-20

Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

Phase 2 Recruiting

Pathologic Complete Response, Head and Neck Neoplasms